Phase 1, open-label, dose-escalation, and expansion study of ABT-700, an anti-C-met antibody, in patients (pts) with advanced solid tumors.
暂无分享,去创建一个
P. LoRusso | Yoon-Koo Kang | L. Naumovski | P. Ansell | C. Yen | Chia‐Chi Lin | J. Strickler | A. Bhathena | R. Ramanathan | P. Kaminker | M. Dudley | S. Wong